ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,064,000 | -59.8% | 35,000 | -65.0% | 0.18% | -65.0% |
| Q1 2017 | $2,647,000 | +3.7% | 100,000 | 0.0% | 0.52% | -20.0% |
| Q4 2016 | $2,552,000 | -12.8% | 100,000 | +66.7% | 0.65% | +50.9% |
| Q4 2015 | $2,926,000 | +17.5% | 60,000 | -40.0% | 0.43% | +34.6% |
| Q3 2015 | $2,490,000 | -21.3% | 100,000 | 0.0% | 0.32% | +2.6% |
| Q2 2015 | $3,164,000 | +4.6% | 100,000 | 0.0% | 0.31% | -17.1% |
| Q3 2014 | $3,024,000 | +338.3% | 100,000 | +400.0% | 0.37% | +136.7% |
| Q1 2014 | $690,000 | -65.2% | 20,000 | -60.0% | 0.16% | -71.4% |
| Q4 2013 | $1,980,000 | – | 50,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |